LAS VEGAS, April 8 /PRNewswire/ - Scheduled for June 5 - 7 at Caesars Palace, THE Aesthetic Show has garnered broad industry support and surpassed previous levels of corporate sponsorship.
Already in the third year of operation, this annual medical education and commercial exhibition event has become one of the largest in the world and a focal point for the high-growth medical aesthetic industry.
THE Aesthetic Show "consolidates all subspecialties and scientific topics related to medical aesthetics into one intensive weekend meeting," explained Michael Moretti, President of Medical Insight, Inc. and Chairman of THE Aesthetic Show.
"As a result of a progressive medical education meeting design concept, this show has quickly become a nexus for the companies that supply over $5 billion of products and services to aesthetic practices each year. Our unique multi-specialty educational format facilitates market expansion while maintaining very high level CME standards."
Mr. Moretti also views the success of THE Aesthetic Show 2009 as a harbinger of near-term recovery for the cosmetic elective procedure market, which has experienced a significant reduction in procedure volume over the past six months due to the global economic recession.
"Increased financial support during this down-cycle in the medical aesthetic market is a clear metric signaling a positive turning point. We track industry performance carefully, and our research data reveals early indicators of a return to previous levels of sustainable growth."
According to a recent research report released by Medical Insight (miinews.com), the global market for aesthetic products is extremely resilient and advanced new aesthetic products will play prominent roles in boosting industry sales to $8.2 billion by 2012.
Procedure volume for all aesthetic treatments will rise by 5.6% per year from 81 million in 2008 to 101 million in 2012. During this time, total fees earned by practitioners will expand by 6.1% annually from $31 billion to $39 billion.
Leading corporate sponsors of THE Aesthetic Show 2009 include: Medical Allergan l (NYSE: AGN), Alma Lasers, Bioform Medical (Nasdaq: BFRM), Candela (Nasdaq: CLZR), Cutera (Nasdaq: CUTR), Cynosure (Nasdaq: CYNO), Dermik Aesthetics (Sanofi-Aventis), Galderma Laboratories, Johnson & Johnson (NYSE: JNJ), Medicis Aesthetics (NYSE: MRX), Merz Pharmaceuticals, Obagi Medical (Nasdaq: OMPI), Palomar Medical Technologies (Nasdaq: PMTI), Sciton, Stiefel Laboratories, Solta Medical (Nasdaq: SLTM) and Syneron (Nasdaq: ELOS).
To register for THE Aesthetic Show or preview the program, visit www.aestheticshow.com
About Medical Insight, Inc.
Medical Insight, Inc. is the industry leader in medical aesthetic market research. Founded by Michael Moretti, Medical Insight, Inc. has reported data for over 20 years on procedure volume and revenues, product sales, new product introductions, market forecasts and trend analysis.
For information on research services offered by Medical Insight, Inc., visit www.MiiNews.com.